InspireMD Inc (NSPR)
2.30
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
2.30
0.00 (0.00%)
After-Hours: 20:00
InspireMD Enterprise Value: 23.39M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 23.39M |
| May 15, 2024 | 23.39M |
| May 14, 2024 | 25.43M |
| May 13, 2024 | 25.88M |
| May 10, 2024 | 18.40M |
| May 09, 2024 | 17.82M |
| May 08, 2024 | 15.48M |
| May 07, 2024 | 15.71M |
| May 06, 2024 | 15.71M |
| May 03, 2024 | 12.90M |
| May 02, 2024 | 13.13M |
| May 01, 2024 | 11.81M |
| April 30, 2024 | 11.49M |
| April 29, 2024 | 11.26M |
| April 26, 2024 | 12.90M |
| April 25, 2024 | 10.91M |
| April 24, 2024 | 9.385M |
| April 23, 2024 | 12.31M |
| April 22, 2024 | 10.79M |
| April 19, 2024 | 15.01M |
| April 18, 2024 | 16.20M |
| April 17, 2024 | 17.79M |
| April 16, 2024 | 18.73M |
| April 15, 2024 | 19.20M |
| April 12, 2024 | 20.37M |
| Date | Value |
|---|---|
| April 11, 2024 | 20.84M |
| April 10, 2024 | 18.03M |
| April 09, 2024 | 19.43M |
| April 08, 2024 | 20.90M |
| April 05, 2024 | 19.66M |
| April 04, 2024 | 19.66M |
| April 03, 2024 | 17.56M |
| April 02, 2024 | 16.39M |
| April 01, 2024 | 21.46M |
| March 31, 2024 | 21.54M |
| March 28, 2024 | 16.57M |
| March 27, 2024 | 14.50M |
| March 26, 2024 | 13.75M |
| March 25, 2024 | 15.16M |
| March 22, 2024 | 16.57M |
| March 21, 2024 | 15.40M |
| March 20, 2024 | 15.16M |
| March 19, 2024 | 15.16M |
| March 18, 2024 | 14.22M |
| March 15, 2024 | 14.69M |
| March 14, 2024 | 17.27M |
| March 13, 2024 | 19.62M |
| March 12, 2024 | 18.68M |
| March 11, 2024 | 20.90M |
| March 08, 2024 | 22.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.29M
Minimum
Nov 10 2022
133.02M
Maximum
Feb 11 2021
3.839M
Average
-1.452M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 890.47M |
| Retractable Technologies Inc | -16.18M |
| Xtant Medical Holdings Inc | 106.24M |
| Asensus Surgical Inc | 63.22M |
| Catheter Precision Inc | 3.203M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.032M |
| Revenue (Quarterly) | 1.511M |
| Total Expenses (Quarterly) | 8.925M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | 19.32% |
| Profit Margin (Quarterly) | -465.4% |
| Earnings Yield | -31.74% |
| Normalized Earnings Yield | -31.74 |